Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P00492 (
hypoxanthine-guanine phosphoribosyltransferase
)
2,385
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Eight Chinese hamster clones (CHO-K1) growing at the 30 mg/ml concentration of 8-azaguanine (AG) were studied. Clones were differentiated by their resistance to AG and to 6-thioguanine, by their plating efficiency on HAT medium, and by the level of hypoxantine incorporation in cells. The differences in phenotypic properties were shown to be associated with variability in
hypoxanthine-guanine phosphoribosyltransferase
(
HPRT
) activity.
HPRT
Michaelis constant (KM) for hypoxanthine and phosphoribosylpyrophosphate, and maximal reaction rate (Vm) offered considerable differences between all the resistant clones and sensitive cells. The only possible reason of these differences is a change in the
HPRT
coding locus. According to the results of the analysis of
B15
-4b-4 subclones, phenotypic and
HPRT
activity differences are also connected with each other; however, all subclones have the same KM of
HPRT
as that of the parental clone. So, differences in
HPRT
activity (and in Vm) may reflect changes in the
HPRT
content in cells of subclones. Hence, phenotypic heterogeneity of AG-resistant clones is determined by the interaction of mutational changes in the
HPRT
locus, and hereditable changes of genetic activity, responsible for variation of
HPRT
quantity in cells.
...
PMID:[Hereditary changes in gene activity as 1 of the causes of phenotypic heterogeneity in 8-azaguanine-resistant Chinese hamster cells (CHO-K1)]. 731 48